Frontier Wealth Management LLC Gilead Sciences, Inc. Transaction History

Frontier Wealth Management LLC

$8.02 Billion
Q2 2022

A detailed history of Frontier Wealth Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Frontier Wealth Management LLC holds 23,247 shares of GILD stock, worth $2.15 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

23,247

Previous 23,247 -0.0%

Holding current value

$2.15 Million

Previous $1.43 Million -0.0%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $106,897 - $120,398	1,852 Added 7.97%	25,099 $1.55 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $42,687 - $53,491	-737 Reduced 3.07%	23,247 $1.43 Million
Q4 2021 Feb 04, 2022	SELL	$64.88 - $73.64 $67,345 - $76,438	-1,038 Reduced 4.15%	23,984 $1.74 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $38,515 - $41,554	-569 Reduced 2.22%	25,022 $1.75 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $80,416 - $87,866	-1,267 Reduced 4.72%	25,591 $1.76 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $26,340 - $30,053	-439 Reduced 1.61%	26,858 $1.74 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $65,600 - $74,748	-1,158 Reduced 4.07%	27,297 $1.59 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $330,434 - $415,463	-5,321 Reduced 15.75%	28,455 $1.8 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $434 - $504	-6 Reduced 0.02%	33,776 $2.6 Million
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $194,528 - $249,163	3,106 Added 10.13%	33,782 $2.53 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $623,840 - $686,204	-10,124 Reduced 24.81%	30,676 $1.99 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $990,283 - $1.09 Million	-15,842 Reduced 27.97%	40,800 $2.59 Million
Q2 2019 Aug 16, 2019	SELL	$61.87 - $69.38 $324,013 - $363,343	-5,237 Reduced 8.46%	56,642 $3.83 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $265,377 - $297,292	-4,244 Reduced 6.42%	61,879 $4.02 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $132,764 - $173,247	2,193 Added 3.43%	66,123 $4.14 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $1.69 Million - $1.87 Million	-23,753 Reduced 27.09%	63,930 $4.94 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $809,248 - $943,956	-12,473 Reduced 12.45%	87,683 $6.21 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $190,185 - $231,856	-2,611 Reduced 2.54%	100,156 $7.55 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $1.08 Million - $1.26 Million	-15,120 Reduced 12.83%	102,767 $7.36 Million
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $1.14 Million - $1.35 Million	-15,744 Reduced 11.78%	117,887 $9.55 Million
Q2 2017 Aug 14, 2017	BUY	N/A	133,631	133,631 $9.46 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Wealth Management LLC with notifications on news.

Account

Frontier Wealth Management LLC Gilead Sciences, Inc. Transaction History